DaVita celebrates kidney care community achievements in year one of largest-ever value-based care program
Rhea-AI Summary
DaVita announced performance year one clinical outcomes achieved through value-based care arrangements with nearly 1,300 nephrologists across the U.S. These efforts are part of the Comprehensive Kidney Care Contracting (CKCC) option within the government's voluntary Kidney Care Choices (KCC) model, which began on Jan. 1, 2022.
Key achievements include:
- 16% industry increase in optimal start rates for kidney patients transitioning to dialysis
- Embedding care team members in 68% of nephrology practices
- Overseeing approximately 31,000 patients across multiple care settings
- 2.4x more DaVita patients having a planned start on home treatment
- 67% of patients screened for depression remission
- 13% increase in patient activation
DaVita's tech-enabled platform and increased CKD education efforts have contributed to these improvements. The company expects continued progress in outcomes and cost savings as the CKCC program evolves.
Positive
- None.
Negative
- None.
News Market Reaction – DVA
On the day this news was published, DVA gained 1.00%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Nephrologists drive transformative outcomes through government's coordinated care program serving high-need patients
These efforts have helped lead the kidney care community through scaled participation and investment in these programs, which are part of the Comprehensive Kidney Care Contracting (CKCC) option within the government's voluntary Kidney Care Choices (KCC) model — a value-based care demonstration that began on Jan. 1, 2022, as the largest government model for kidney care.
"This program relies on the understanding that kidney care in the
Together with participating nephrologists, DaVita launched 11 value-based care arrangements in 2022 and has since doubled that footprint to 22 Kidney Contracting Entities (KCEs). An evaluation now available for the first performance year (PY1) demonstrates that these value-based care arrangements result in better patient outcomes, which, over time, should lead to decreasing cost expenditures. This includes engaging patients in their care earlier and supporting access to kidney transplants for patients managing their kidney health.
Physicians and providers in the CKCC program improved outcomes for patients through collective quality metrics, with a
"Our focus at the launch of the program was to provide robust support for our nephrology partners, and we're encouraged by the current momentum. Though scaled transformation takes time, we continue to trend positively into the third year of the program," said Dr. Amy Schuerman-Gen, chief medical officer for DaVita Integrated Kidney Care (DaVita IKC). "Our vision for care innovation is taking shape, with CKCC laying a vital foundation for lasting change. The model's emphasis on care coordination and patient engagement has already led to encouraging health outcomes, and we're optimistic about the program's potential for continued success."
DaVita and its nephrologist partners have already seen significant progress over the course of the CKCC program and expect the impact on outcomes and cost savings will continue to improve. Achievements include:
- Embedding care team members in
68% of nephrology practices, providing care to shared patients directly at the site of care. - Overseeing approximately 31,000 patients across dialysis centers of multiple providers, remotely, and in nephrologist offices.
- Enabling 2.4x more DaVita patients to have a planned start on home treatment through patient education, care management and transition support.
- Screening
67% of patients for depression remission with a baseline PHQ-9 across 11 KCEs, supporting holistic care of both physical and mental health. - Increasing patient activation by
13% , indicating higher patient engagement across patient populations — inclusive of people with chronic kidney disease (CKD) and people with end-stage kidney disease (ESKD) who do not treat at DaVita.
Care coordination is fueled in part by DaVita's tech-enabled platform, with more than half of participants either leveraging DaVita's co-designed EHR with Epic or allowing DaVita access to another platform. This foundation helps to meet patients earlier with crucial identification and education to help slow progression to kidney failure and avoid dialysis. From PY1 to current year-to-date, DaVita has increased CKD education by
From coast to coast, participation in CKCC has allowed for a broad evaluation of the positive impact value-based care at scale can have for kidney patients.
"As we continue in the CKCC demonstration, I look forward to working collaboratively with our DaVita IKC partners and others to tackle difficult challenges we face in patient-centered care," said Dr. Alec Otteman of Associated Nephrology Consultants in
For more information about DaVita IKC's programs and results, visit DaVita.com/IKC
About DaVita Inc.
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June 30, 2024, DaVita served approximately 265,100 patients at 3,124 outpatient dialysis centers, of which 2,672 centers were located in the United States and 452 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere. To learn more, visit DaVita.com/About.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements that are subject to risks and uncertainties. These forward-looking statements are based on management's current expectations. Various important factors could cause actual results to differ materially from these forward-looking statements, including the risks identified in our
The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document.
Media Contact:
DaVita Newsroom
newsroom@davita.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/davita-celebrates-kidney-care-community-achievements-in-year-one-of-largest-ever-value-based-care-program-302282733.html
SOURCE DaVita
